1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Carboplatin + Paclitaxel + Cetuximab (PCC) After Failure of Pembrolizumab +/- First-line Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and NeckHead and Neck Neoplasms, Neoplasms by Site, head and neck cancer, neoplasmRecruitingPhase 22025-12-23NCT06725368